10-Q Filing

GLUCOSE HEALTH, INC. CIK: 1420108 Q3 2013

Filing Information

Form Type	10-Q
Accession Number	`0001477932-13-005415`
Period End Date	20130930
Filing Date	20131114
Fiscal Year	2013
Fiscal Period	Q3
XBRL Instance	bisu-20130930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 50 Income Statement 83 Cash Flow Statement 72

Balance Sheet 50 line items

Line Item	Tag	Value	Unit	Period
Cash	`Cash`	$269.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash	`Cash`	$1.08K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Inventory	`InventoryNet`	$27.90K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Inventory	`InventoryNet`	-	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$4.96K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	-	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	174.77M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	101.09M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	174.77M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$33.13K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	101.09M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.08K	USD	Point-in-time
Intellectual Property	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$206.60K	USD	Point-in-time
Intellectual Property	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$431.60K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$207.68K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$464.73K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$123.08K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$123.20K	USD	Point-in-time
Liability for stock to be issued	`LiabilityForStockToBeIssued`	$20.00K	USD	Point-in-time
Liability for stock to be issued	`LiabilityForStockToBeIssued`	-	USD	Point-in-time
Short - term loans	`NotesPayableCurrent`	$6.00K	USD	Point-in-time
Short - term loans	`NotesPayableCurrent`	-	USD	Point-in-time
Short - term loans - related parties	`DueToRelatedPartiesCurrent`	$1.60K	USD	Point-in-time
Short - term loans - related parties	`DueToRelatedPartiesCurrent`	$1.65K	USD	Point-in-time
Short - term loans - convertible	`ConvertibleNotesPayableCurrent`	$60.68K	USD	Point-in-time
Short - term loans - convertible	`ConvertibleNotesPayableCurrent`	$91.72K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$185.48K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$242.45K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$242.45K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$185.48K	USD	Point-in-time
Common stock, $0.001 par value, 200,000,000 shares authorized, 174,768,593 and 101,085,862 shares issued and outstanding as of September 30, 2013 and December 31, 2012, respectively	`CommonStockValue`	$174.77K	USD	Point-in-time
Common stock, $0.001 par value, 200,000,000 shares authorized, 174,768,593 and 101,085,862 shares issued and outstanding as of September 30, 2013 and December 31, 2012, respectively	`CommonStockValue`	$101.09K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$3.59M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$4.38M	USD	Point-in-time
Deferred Compensation	`DeferredCompensationLiabilityCurrent`	$-150.00K	USD	Point-in-time
Deferred Compensation	`DeferredCompensationLiabilityCurrent`	$-92.43K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-2.87M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-2.87M	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$1.30M	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$568.65K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-75.28K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-75.28K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$22.20K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$222.28K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$464.73K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$207.68K	USD	Point-in-time

Income Statement 83 line items

Line Item	Tag	Value	Unit	Period
REVENUE	`SalesRevenueGoodsNet`	-	USD	3 Qtrs
REVENUE	`SalesRevenueGoodsNet`	-	USD	1 Quarter
REVENUE	`SalesRevenueGoodsNet`	$224.00	USD	3 Qtrs
REVENUE	`SalesRevenueGoodsNet`	$224.00	USD	1 Quarter
REVENUE	`SalesRevenueGoodsNet`	$224.00	USD	8 Qtrs
COST OF REVENUES	`CostOfGoodsSold`	$13.07K	USD	3 Qtrs
COST OF REVENUES	`CostOfGoodsSold`	-	USD	1 Quarter
COST OF REVENUES	`CostOfGoodsSold`	$16.71K	USD	8 Qtrs
COST OF REVENUES	`CostOfGoodsSold`	-	USD	3 Qtrs
COST OF REVENUES	`CostOfGoodsSold`	$13.07K	USD	1 Quarter
GROSS LOSS	`GrossProfit`	$-12.85K	USD	1 Quarter
GROSS LOSS	`GrossProfit`	$-12.85K	USD	3 Qtrs
GROSS LOSS	`GrossProfit`	-	USD	1 Quarter
GROSS LOSS	`GrossProfit`	$-16.48K	USD	8 Qtrs
GROSS LOSS	`GrossProfit`	-	USD	3 Qtrs
Professional fees/stock based compensation	`ShareBasedCompensation`	$1.12M	USD	8 Qtrs
Professional fees/stock based compensation	`ShareBasedCompensation`	$232.10K	USD	3 Qtrs
Professional fees/stock based compensation	`ShareBasedCompensation`	$214.61K	USD	1 Quarter
Professional fees/stock based compensation	`ShareBasedCompensation`	$208.33K	USD	1 Quarter
Professional fees/stock based compensation	`ShareBasedCompensation`	$680.09K	USD	3 Qtrs
Amortization expense and impairment	`AmortizationExpenseAndImpairment`	-	USD	1 Quarter
Amortization expense and impairment	`AmortizationExpenseAndImpairment`	-	USD	3 Qtrs
Amortization expense and impairment	`AmortizationExpenseAndImpairment`	-	USD	1 Quarter
Amortization expense and impairment	`AmortizationExpenseAndImpairment`	-	USD	3 Qtrs
Amortization expense and impairment	`AmortizationExpenseAndImpairment`	$85.29K	USD	8 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$632.00	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$5.12K	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$18.19K	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$5.60K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$24.47K	USD	8 Qtrs
Total Operating Expenses	`OperatingExpenses`	$208.97K	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$698.28K	USD	3 Qtrs
Total Operating Expenses	`OperatingExpenses`	$1.23M	USD	8 Qtrs
Total Operating Expenses	`OperatingExpenses`	$237.22K	USD	3 Qtrs
Total Operating Expenses	`OperatingExpenses`	$220.21K	USD	1 Quarter
NET LOSS BEFORE OTHER INCOME (EXPENSE)	`OperatingIncomeLoss`	$-233.06K	USD	1 Quarter
NET LOSS BEFORE OTHER INCOME (EXPENSE)	`OperatingIncomeLoss`	$-1.24M	USD	8 Qtrs
NET LOSS BEFORE OTHER INCOME (EXPENSE)	`OperatingIncomeLoss`	$-208.97K	USD	1 Quarter
NET LOSS BEFORE OTHER INCOME (EXPENSE)	`OperatingIncomeLoss`	$-237.22K	USD	3 Qtrs
NET LOSS BEFORE OTHER INCOME (EXPENSE)	`OperatingIncomeLoss`	$-711.13K	USD	3 Qtrs
Interest income (expense)	`InterestExpense`	$73.97K	USD	1 Quarter
Interest income (expense)	`InterestExpense`	$-107.49K	USD	1 Quarter
Interest income (expense)	`InterestExpense`	$238.03K	USD	3 Qtrs
Interest income (expense)	`InterestExpense`	$30.94K	USD	8 Qtrs
Interest income (expense)	`InterestExpense`	$-5.24K	USD	3 Qtrs
Loss on conversion of debt	`LossOnConversionOfDebt`	-	USD	3 Qtrs
Loss on conversion of debt	`LossOnConversionOfDebt`	$21.00K	USD	1 Quarter
Loss on conversion of debt	`LossOnConversionOfDebt`	-	USD	1 Quarter
Loss on conversion of debt	`LossOnConversionOfDebt`	$21.00K	USD	3 Qtrs
Loss on conversion of debt	`LossOnConversionOfDebt`	$21.00K	USD	8 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-51.94K	USD	8 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-73.97K	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-15.77K	USD	3 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-238.03K	USD	3 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$86.49K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-146.57K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-726.90K	USD	3 Qtrs
NET LOSS	`NetIncomeLoss`	$-1.30M	USD	8 Qtrs
NET LOSS	`NetIncomeLoss`	$-282.94K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-475.25K	USD	3 Qtrs
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	69.40M	shares	3 Qtrs
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	167.95M	shares	1 Quarter
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	136.69M	shares	3 Qtrs
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	73.77M	shares	1 Quarter
NET LOSS PER SHARE	`EarningsPerShareBasic`	$-0.00	USD	1 Quarter
NET LOSS PER SHARE	`EarningsPerShareBasic`	$-0.00	USD	1 Quarter
NET LOSS PER SHARE	`EarningsPerShareBasic`	$-0.01	USD	3 Qtrs
NET LOSS PER SHARE	`EarningsPerShareBasic`	$-0.00	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-146.57K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-726.90K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-1.30M	USD	8 Qtrs
Net loss	`NetIncomeLoss`	$-282.94K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-475.25K	USD	3 Qtrs
Currency translation gains (losses)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	-	USD	3 Qtrs
Currency translation gains (losses)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-12.58K	USD	8 Qtrs
Currency translation gains (losses)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	-	USD	1 Quarter
Currency translation gains (losses)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-6.65K	USD	1 Quarter
Currency translation gains (losses)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-6.59K	USD	3 Qtrs
TOTAL ACCUMULATED OTHER COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-146.57K	USD	1 Quarter
TOTAL ACCUMULATED OTHER COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-289.59K	USD	1 Quarter
TOTAL ACCUMULATED OTHER COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-1.31M	USD	8 Qtrs
TOTAL ACCUMULATED OTHER COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-726.90K	USD	3 Qtrs
TOTAL ACCUMULATED OTHER COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-481.84K	USD	3 Qtrs

Cash Flow Statement 72 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-146.57K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-726.90K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-1.30M	USD	8 Qtrs
Net loss	`NetIncomeLoss`	$-282.94K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-475.25K	USD	3 Qtrs
Impairment expense	`AssetImpairmentCharges`	$85.29K	USD	8 Qtrs
Impairment expense	`AssetImpairmentCharges`	-	USD	3 Qtrs
Impairment expense	`AssetImpairmentCharges`	-	USD	3 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$613.62K	USD	3 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$965.99K	USD	8 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$169.00K	USD	3 Qtrs
Beneficial Conversion Feature of Notes Payable	`DebtInstrumentConvertibleBeneficialConversionFeature`	$-25.46K	USD	8 Qtrs
Beneficial Conversion Feature of Notes Payable	`DebtInstrumentConvertibleBeneficialConversionFeature`	$8.84K	USD	3 Qtrs
Beneficial Conversion Feature of Notes Payable	`DebtInstrumentConvertibleBeneficialConversionFeature`	$-235.54K	USD	3 Qtrs
Loss on coversion of debt	`LossOnConversionOfDebt`	-	USD	3 Qtrs
Loss on coversion of debt	`LossOnConversionOfDebt`	$21.00K	USD	1 Quarter
Loss on coversion of debt	`LossOnConversionOfDebt`	-	USD	1 Quarter
Loss on coversion of debt	`LossOnConversionOfDebt`	$21.00K	USD	3 Qtrs
Loss on coversion of debt	`LossOnConversionOfDebt`	$21.00K	USD	8 Qtrs
(Increase) decrease in accounts receivable	`IncreaseDecreaseInAccountsReceivable`	-	USD	3 Qtrs
(Increase) decrease in accounts receivable	`IncreaseDecreaseInAccountsReceivable`	-	USD	3 Qtrs
(Increase) decrease in accounts receivable	`IncreaseDecreaseInAccountsReceivable`	-	USD	8 Qtrs
(Increase) decrease in inventory	`IncreaseDecreaseInInventories`	$27.90K	USD	3 Qtrs
(Increase) decrease in inventory	`IncreaseDecreaseInInventories`	$27.90K	USD	8 Qtrs
(Increase) decrease in inventory	`IncreaseDecreaseInInventories`	-	USD	3 Qtrs
(Increase) decrease in prepaids	`IncreaseDecreaseInPrepaidExpense`	$4.96K	USD	3 Qtrs
(Increase) decrease in prepaids	`IncreaseDecreaseInPrepaidExpense`	-	USD	3 Qtrs
(Increase) decrease in prepaids	`IncreaseDecreaseInPrepaidExpense`	$4.96K	USD	8 Qtrs
Increase (decrease) in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$4.03K	USD	3 Qtrs
Increase (decrease) in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$17.56K	USD	8 Qtrs
Increase (decrease) in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$9.55K	USD	3 Qtrs
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$1.08M	USD	8 Qtrs
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$602.47K	USD	3 Qtrs
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$408.57K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-213.12K	USD	8 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-66.68K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-124.43K	USD	3 Qtrs
Proceeds from short-term loans, net of repayments	`ProceedsFromRepaymentsOfShortTermDebt`	$10.61K	USD	8 Qtrs
Proceeds from short-term loans, net of repayments	`ProceedsFromRepaymentsOfShortTermDebt`	$12.00K	USD	3 Qtrs
Proceeds from short-term loans, net of repayments	`ProceedsFromRepaymentsOfShortTermDebt`	-	USD	3 Qtrs
Proceeds from short-term loans - related party, net of repayments	`ShorttermLoansRelatedPartyNetOfRepayments`	$4.87K	USD	8 Qtrs
Proceeds from short-term loans - related party, net of repayments	`ShorttermLoansRelatedPartyNetOfRepayments`	-	USD	3 Qtrs
Proceeds from short-term loans - related party, net of repayments	`ShorttermLoansRelatedPartyNetOfRepayments`	-	USD	3 Qtrs
Proceeds from convertible notes payable, net of repayments	`ProceedsFromRepaymentsOfOtherDebt`	$188.47K	USD	8 Qtrs
Proceeds from convertible notes payable, net of repayments	`ProceedsFromRepaymentsOfOtherDebt`	$111.62K	USD	3 Qtrs
Proceeds from convertible notes payable, net of repayments	`ProceedsFromRepaymentsOfOtherDebt`	$61.60K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$123.62K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$203.95K	USD	8 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$61.60K	USD	3 Qtrs
Effect of foreign currency	`EffectOfExchangeRateOnCashAndCashEquivalents`	$5.27K	USD	3 Qtrs
Effect of foreign currency	`EffectOfExchangeRateOnCashAndCashEquivalents`	-	USD	3 Qtrs
Effect of foreign currency	`EffectOfExchangeRateOnCashAndCashEquivalents`	$5.51K	USD	8 Qtrs
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-807.00	USD	3 Qtrs
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-3.66K	USD	8 Qtrs
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$195.00	USD	3 Qtrs
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$3.93K	USD	Point-in-time
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.08K	USD	Point-in-time
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$82.00	USD	Point-in-time
CASH AND CASH EQUIVALENTS - END OF PERIOD	`CashEquivalentsAtCarryingValue`	$277.00	USD	Point-in-time
CASH AND CASH EQUIVALENTS - END OF PERIOD	`CashEquivalentsAtCarryingValue`	$269.00	USD	Point-in-time
Conversion of notes payable and accrued interest to common stock	`DebtConversionConvertedInstrumentAmount1`	$174.96K	USD	8 Qtrs
Conversion of notes payable and accrued interest to common stock	`DebtConversionConvertedInstrumentAmount1`	$110.82K	USD	3 Qtrs
Conversion of notes payable and accrued interest to common stock	`DebtConversionConvertedInstrumentAmount1`	$14.10K	USD	3 Qtrs
Conversion of liability to common stock	`StockIssued1`	$41.50K	USD	3 Qtrs
Conversion of liability to common stock	`StockIssued1`	$6.38K	USD	3 Qtrs
Conversion of liability to common stock	`StockIssued1`	$54.17K	USD	8 Qtrs
Acquisition of intellectual property of Type2 Defense for common shares	`StockIssued2`	-	USD	3 Qtrs
Acquisition of intellectual property of Type2 Defense for common shares	`StockIssued2`	$231.60K	USD	8 Qtrs
Acquisition of intellectual property of Type2 Defense for common shares	`StockIssued2`	$225.00K	USD	3 Qtrs
Conversion of accounts payable and notes payable to equity (Note 9)	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	$217.81K	USD	3 Qtrs
Conversion of accounts payable and notes payable to equity (Note 9)	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	$291.56K	USD	8 Qtrs
Conversion of accounts payable and notes payable to equity (Note 9)	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	-	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.